A
Ann L. Anderson
Researcher at National Institute on Drug Abuse
Publications - 12
Citations - 751
Ann L. Anderson is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Abstinence & Modafinil. The author has an hindex of 9, co-authored 12 publications receiving 684 citations. Previous affiliations of Ann L. Anderson include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Bupropion for the Treatment of Methamphetamine Dependence
Ahmed Elkashef,Richard A. Rawson,Ann L. Anderson,Shou-Hua Li,Tyson H. Holmes,Edwina V. Smith,Nora Chiang,Roberta Kahn,Frank Vocci,Walter Ling,Valerie Pearce,Michael McCann,Jan Campbell,Charles Gorodetzky,William Haning,Barry S. Carlton,Joseph Mawhinney,Dennis Weis +17 more
TL;DR: The data suggest that bupropion, in combination with behavioral group therapy, was effective for increasing the number of weeks of abstinence in participants with low-to-moderate methamphetamine dependence, mainly male patients, regardless of their comorbid condition.
Journal ArticleDOI
Modafinil for the treatment of cocaine dependence.
Ann L. Anderson,Malcolm S. Reid,Shou Hua Li,Tyson H. Holmes,Lynn Shemanski,April Slee,Edwina V. Smith,Roberta Kahn,Nora Chiang,Frank Vocci,Domenic A. Ciraulo,Charles A. Dackis,John D. Roache,Ihsan M. Salloum,Eugene Somoza,Harold C. Urschel,Ahmed Elkashef +16 more
TL;DR: Data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.
Journal ArticleDOI
Modafinil for the treatment of methamphetamine dependence.
Ann L. Anderson,Shou-Hua Li,Kousick Biswas,Frances McSherry,Tyson H. Holmes,Erin Iturriaga,Roberta Kahn,Nora Chiang,Thomas P. Beresford,Jan Campbell,William Haning,Joseph Mawhinney,Michael J. McCann,Richard A. Rawson,Christopher Stock,Dennis Weis,Elmer Yu,Ahmed Elkashef +17 more
TL;DR: Data suggest that modafinil, plus group behavioral therapy, was not effective for decreasing methamphetamine use, and the study is probably inconclusive because of inadequate compliance with taking medication.
Journal ArticleDOI
Topiramate for the treatment of methamphetamine addiction: a multi‐center placebo‐controlled trial
Ahmed Elkashef,Roberta Kahn,Elmer Yu,Erin Iturriaga,Shou-Hua Li,Ann L. Anderson,Nora Chiang,Nassima Ait-Daoud,David J. Weiss,Frances McSherry,Tracey Serpi,Richard A. Rawson,Mark Hrymoc,Dennis Weis,Michael McCann,Tony Pham,Christopher Stock,Ruth Dickinson,Jan Campbell,Charles Gorodetzky,William Haning,Barry S. Carlton,Joseph Mawhinney,Ming D. Li,Bankole A. Johnson +24 more
TL;DR: Topiramate does not appear to promote abstinence in methamphetamine users but can reduce the amount taken and reduce relapse rates in those who are already abstinent.
Journal ArticleDOI
Evaluation of Subjective Effects of Aripiprazole and Methamphetamine in Methamphetamine-Dependent Volunteers
Thomas F. Newton,Malcolm S. Reid,Richard De La Garza,James J. Mahoney,Antonio Abad,Rany Condos,Joseph J. Palamar,Perry N. Halkitis,Jurji Mojisak,Ann L. Anderson,Shou Hua Li,Ahmed Elkashef +11 more
TL;DR: It is suggested that 15 mg aripiprazole is unlikely to be efficacious for the treatment of Meth dependence, although further research with lower doses of aripIPrazole, possibly using study designs aimed at evaluating efficacy for relapse prevention, are needed before ruling out arip iprazole as a treatment for Meth dependence.